Background: Cell migration (restitution) occurs in the early phase of gastric ulcer healing. Tumor necrosis factor (TNF)-α is overexpressed at the ulcer margin and plays a physiologic role in gastric ulcer healing. Dexamethasone, which is a potent corticosteroid, delays rat gastric ulcer healing. We evaluated whether dexamethasone inhibited TNF-α-stimulated gastric epithelial cell migration using a rat normal gastric epithelial cell line (RGM-1). Methods: An artificial wound model was employed to measure cell migration. Western blot was performed to evaluate the possible mechanisms. Intracellular prostaglandin E 2 level was measured using an enzyme-linked immunosorbent assay. Results: TNF-α treatment (10 ng/mL) for 12-48 hours significantly increased RGM-1 cell migration, and TNF-α treatment increased cyclooxygenase (COX)-2 protein expression 8 hours later and prostaglandin E 2 (PGE 2 ) synthesis 12 hours later compared with control (p < 0.05). Dexamethasone (10 -6 M) significantly inhibited the stimulatory effect of TNF-α on RGM-1 cell migration, which was associated with a significant decrease in COX-2 expression and PGE 2 level in cells (p < 0.05). Conclusion: TNF-α plays a regulatory role in rat gastric epithelial cell migration and dexamethasone inhibited TNF-α-stimulated cell migration, which was associated with a decrease in COX-2 expression and PGE 2 formation. [J Chin Med Assoc 2009;72(10):509-514] 
Introduction
Ulcer formation is a dynamic imbalance between mucosal aggressive factors and defensive factors. When the function of defense and repairing factors is less than that of aggressive factors, mucosal injury worsens, and finally ulcer formation develops. Ulcer healing and repair requires a reconstruction of the surface epithelium and underlying connective tissue, including blood vessels and muscle layers. 1 The early phase of mucosal repair occurs in the absence of cellular proliferation and is termed restitution or cell migration. 2, 3 The late phase of repair of deeper tissue damage involves cell proliferation as well as angiogenesis of granulation tissue to reconstruct the mucosal and submucosal architecture. 1, 4 All of these events are controlled and regulated by cytokines, growth factors, and some transcription factors that are overexpressed or activated over injured mucosa or ulcer margins. [5] [6] [7] In general, re-epithelialization, the migration of epithelial cells from the wound margin to restore epithelial continuity, is essentially an early process for gastrointestinal ulcer healing. 2, 8, 9 Cell migration requires cytoskeletal rearrangement: actin microfilament assembly, stress fiber and lamelipodia formation, as well as rearrangement of focal adhesion complex attachments to the extracellular matrix. 10 Growth factors such as epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), and hepatocyte growth factor (HGF), as well as cytokines such as tumor necrosis
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Factor-a-stimulated Gastric Epithelial Cell Migration The expression of TNF-α is increased at ulcer sites in rat stomachs; TNF-α is presumably secreted from macrophages and mononuclear cells.
2,11 TNF-α has been reported to indirectly stimulate cell migration, partially through the increased production of HGF and IL-8. 2, 12 Our previous in vivo studies demonstrated that dexamethasone, which is a potent corticosteroid, delayed rat gastric ulcer healing by inhibiting epithelial cell proliferation and angiogenesis at the ulcer margin. 1, 4 Our previous in vitro study also showed that dexamethasone inhibited TNF-α-stimulated gastric epithelial cell proliferation via inhibition of arachidonic acidcyclooxygenase (COX)-2 pathway activation. 13 In this in vitro study, we evaluated whether dexamethasone inhibited TNF-α-stimulated gastric epithelial cell migration and explored the possible mechanistic pathways. The findings further explained the mechanisms of how glucocorticoids delay gastric ulcer healing.
Methods
All study chemicals were purchased from Sigma (Sigma Chemical Co., St Louis, MO, USA) unless otherwise specified. Ten μg TNF-α (human, recombinant) was prepared in 2 mL of 0.01 M phosphate buffer saline at pH 7.4 containing 0.1% bovine serum albumin as a stock solution.
Cell culture
The RGM-1 rat gastric mucosal cells were established from normal Wistar rats and were a gift from Dr Hirofumi Matsui of Tsukuba University (RCB-0876 at Riken Cell Bank, Tsukuba, Japan). RGM-1 cells are epithelial in origin and like mucous epithelial or mucous neck cells. 14, 15 Ours were grown in Dulbecco's modified Eagle's medium (DMEM)/F-12 medium (Gibco BRL, Grand Island, NY, USA) supplemented with 100 U/mL penicillin G, 100 μg/mL streptomycin, and 20% fetal bovine serum (FBS) (Gibco BRL) in an incubator at 37°C and 5% carbon dioxide.
Cell migration
Cells were seeded in 24-well culture plates and cultured in DMEM/F-12 with 20% FBS until confluence. After confluence, monolayers of the cells were starved for 24 hours in the medium containing 1% FBS. The cells were then pretreated with mitomycin C (2 μg/mL) for 2 hours before a wound was made to inhibit cell proliferation. 16, 17 This dose and treatment duration of mitomycin almost abolished 10% of FBSinduced RGM-1 cell proliferation as reflected by a 96% decrease in BrdU (5-bromo-2Ј-deoxy-uridine) labeling compared to cells incubated with medium alone at 48 hours. 10 An artificial circular wound of cell-free area 2 mm 2 was made in the center of the monolayer using a plastic blade. 16, 18 The wounded monolayer was then cultured in the medium with 1% FBS in the presence of control, or TNF-α alone (2 and 10 ng/mL), or TNF-α (10 ng/mL) with dexamethasone (10 -8 M and 10 -6 M), or dexamethasone alone (10 -8 M and 10 -6 M). The size of the cell-free area was monitored from time 0 to 48 hours using a digital image processor connected to a microscope (Nikon, Tokyo, Japan). 18 The areas were calculated with an image-analyzing program (Leica, Cambridge, England).
Western blot analysis for COX-1, COX-2, EGF, and bFGF
After synchronization and pretreatment with mitomycin C as described above, cells were treated with DMEM/F-12 containing 1% FBS and 10 ng/mL TNF-α in the presence or absence of 10 -6 M dexamethasone, or 10 -6 M dexamethasone alone for 8 hours. Cells were then collected in radioimmunoprecipitation assay buffer for Western blot analysis. Following sonication and centrifugation, protein concentration was measured using a protein assay kit (BioRad Laboratories, Hercules, CA, USA). Proteins were separated by SDS-polyacrylamide electrophoresis gel overlaid with a 10% acrylamide stacking gel, and then transferred to Hybond C nitrocellulose membranes (Amersham International Plc., Amersham, UK). Membranes were probed with antibodies against COX-1 (1:800), COX-2 (1:500), EGF (1:500), bFGF (1:500), and β-actin (1:2,000) (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) overnight at 4°C and incubated for 1 hour with secondary antibodies conjugated with peroxidase. The membrane was developed using an enhanced chemiluminescence system (Amersham Biosciences, Piscataway, NJ, USA) and was exposed to X-ray film (Fuji Photo Film, Tokyo, Japan). Quantitation was performed using a densitometer (Scan Marker III; Microtek, Carson, NV, USA).
Measurement of PGE 2 level
After synchronization and pretreatment with mitomycin C as described above, cells were treated with 10 ng/mL TNF-α in the presence or absence of dexamethasone (10 -8 M and 10 -6 M), or dexamethasone (10 -6 M) alone for 12 hours. Then, cells were homogenized with homogenizing buffer (0.05 M Tris-HCl at pH 7.4, 0.1 M NaCl, 0.001 M CaCl 2 , 1 mg/mL D-glucose, 28 μM indomethacin to inhibit further PGE 2 formation) for 30 seconds. 15 After centrifugation at 24,148g for 15 minutes at 4°C, the supernatants were assayed using a commercially available PGE 2 enzyme-linked immunosorbent assay (Quantikine; R&D Systems Inc., Minneapolis, MN, USA). The assay procedures were in accordance with the protocol suggested in the kit. Optical densities were determined with the MRX microplate reader (Dynex Technologies Inc., Chantilly, VA, USA) at 405 nm. The amount of protein in the sample was determined by a protein assay kit, and the intracellular PGE 2 level was expressed as pg/mg protein.
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Statistical analysis
Analytic results are expressed as mean ± standard deviation. There were six samples in each group. Differences between the means were analyzed with the Mann-Whitney U test when appropriate. Bonferroni correction was performed to adjust for the fact that multiple comparisons were done in each experiment. A p value < 0.05 was considered to be statistically significant.
Results
Effects of TNF-a on cell migration in RGM-1 cells
Treatment with TNF-α 2 ng/mL increased RGM-1 cell migration, but there was no significant difference when compared with control after 12, 24, 36 and 48 hours of treatment. However, treatment with TNF-α 10 ng/mL for 12, 24, 36 and 48 hours significantly increased cell migration when compared with control ( Figure 1) . Thereafter, we chose 10 ng/mL TNF-α as the working concentration for subsequent experiments in this study.
Effects of dexamethasone on cell migration in RGM-1 cells
Dexamethasone treatment alone (10 -8 M and 10 -6 M) for 12, 24, 36 and 48 hours did not have a stimulatory or inhibitory action on RGM-1 cell migration when compared with that of control (Figure 2 ). no significant difference between the TNF-α plus dexamethasone group and the control group (Figure 3) .
Effects of dexamethasone on TNF-a stimulated RGM-1 cell migration
Effects of TNF-a and dexamethasone on protein expression of COX-1, COX-2, EGF and bFGF
Treatment with TNF-α 10 ng/mL for 8 hours significantly increased COX-2 expression when compared with that of the control group. In contrast, dexamethasone (10 -6 M) alone did not decrease COX-2 expression when compared with the control group (Figure 4) . However, the same concentrations of dexamethasone (10 -6 M) significantly decreased TNF-α-stimulated COX-2 expression when compared with the TNF-α-treated group (Figure 4 ). There were no significant differences in the expressions of COX-1, EGF and bFGF among the different treatment groups, including the control, TNF-α alone, dexamethasone alone, and TNF-α plus dexamethasone treated groups (data not shown).
Effects of TNF-a and dexamethasone on intracellular PGE 2 level
Treatment with TNF-α 10 ng/mL for 12 hours significantly increased intracellular PGE 2 level when compared with that of the control group ( Figure 5 ). Again, dexamethasone treatment (10 -8 M and 10 -6 M) decreased PGE 2 level in the TNF-α-treated group and reached a significant difference in the higher concentration group (10 -6 M dexamethasone) ( Figure 5 ).
Discussion
Our study demonstrated that TNF-α increased COX-2 expression and PGE 2 formation, and stimulated rat gastric epithelial (RGM-1) cell migration. Dexamethasone inhibited TNF-α-stimulated RGM-1 cell migration, which was associated with a decrease in COX-2 expression and PGE 2 formation. These findings further explain the reasons and mechanisms for how glucocorticoids delay gastric ulcer healing. Our previous study showed that TNF-α (2 and 10 ng/mL) and dexamethasone (10 -8 M and 10 -6 M)
alone did not alter cell viability (by MTT [3-(4,5-dimethyl-thiazol-2yl)-2,5-diphenyltetrazolium bromide] reduction method) or induce RGM-1 cell apoptosis (by DNA laddering), respectively. 13 That study also showed that TNF-α, which was overexpressed in the gastric ulcer margin, 11 played a positive role in RGM-1 cell proliferation via activating the arachidonic acid-COX-2 pathway, which is important for mucosal defense and ulcer healing. 1, 13 The current study showed that TNF-α at the same concentration (10 ng/mL) significantly stimulated COX-2 expression and PGE 2 formation, and increased RGM-1 cell migration, which is the initial step in mucosal repair before cellular proliferation. In fact, activation of the COX-2 pathway is essential for cell migration. 19, 20 TNF-α also upregulated the production of HGF and IL-8, which promoted cell migration. 2, 12, 20 This study also revealed that dexamethasone inhibited TNF-α-stimulated COX-2 expression and PGE 2 formation, and inhibited TNF-α-stimulated RGM-1 cell migration. It was interesting to find that dexamethasone alone did not have an inhibitory action on basal RGM-1 cell migration when compared with that of control, but did have an inhibitory action on TNF-α-stimulated cell migration when compared with the TNF-α-treated group. The findings are in agreement with data showing that COX-2 expression and intracellular PGE 2 levels were comparable between the control group and the dexamethasone (10 -6 M) group, although COX-2 expression and PGE 2 synthesis were a little weaker in the dexamethasone group than in the control group. Further study is needed to clarify why dexamethasone alone did not have an inhibitory action on basal RGM-1 cell migration.
The concentrations of dexamethasone (10 -8 M and 10 -6 M) we used in this study are similar to the pharmacologic concentration that is found in the plasma of patients treated with dexamethasone. 20, 21 Putting together the findings of our previous studies and the current study, we demonstrated that dexamethasone inhibited EGF, bFGF, TNF-α-stimulated RGM-1 cell proliferation, and TNF-α-stimulated RGM-1 cell migration. 13, 15, 22 We also found that dexamethasone inhibited EGF, bFGF, and TNF-α-stimulated COX-2 expression. These findings also support our previous studies that showed that dexamethasone delayed rat gastric ulcer healing via inhibition of epithelial cell proliferation in ulcer margins and angiogenesis of ulcer base. 1, 4 In conclusion, TNF-α increased COX-2 expression and PGE 2 formation, and stimulated rat gastric epithelial (RGM-1) cell migration. Dexamethasone inhibited TNF-α-stimulated RGM-1 cell migration, which was associated with a decrease in COX-2 expression and PGE 2 formation.
